1 beta-d-arabinofuranosylcytosine 5'-diphosphate-l-1,2 dipalmitin has been researched along with Leukemia L 1210 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, CI; MacCoss, M; Matsushita, T; Ryu, EK | 1 |
| An, SH; Buchheit, DJ; Hong, CI; Kirisits, AJ; Nechaev, A; Schliselfeld, L; West, CR | 1 |
| An, SH; Berdel, WE; Buchheit, DJ; Hong, CI; Kirisits, AJ; Nechaev, A; West, CR | 1 |
3 other study(ies) available for 1 beta-d-arabinofuranosylcytosine 5'-diphosphate-l-1,2 dipalmitin and Leukemia L 1210
| Article | Year |
|---|---|
Phospholipid derivatives of nucleoside analogs as prodrugs with enhanced catabolic stability.
Topics: Animals; Biotransformation; Cell Division; Cell Line; Cytarabine; Cytidine Diphosphate Diglycerides; Deamination; Delayed-Action Preparations; Injections, Intraperitoneal; Leukemia L1210; Mice; Neoplasm Transplantation; Prognosis; Ribonucleosides; Technology, Pharmaceutical; Tubercidin; Vidarabine | 1981 |
Nucleoside conjugates. 10. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine 5'-diphosphate-1,2-dipalmitins.
Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Cytarabine; Drug Resistance; Drug Therapy; Leukemia L1210; Mice; Mice, Inbred DBA; Prodrugs; Stereoisomerism; Structure-Activity Relationship | 1988 |
Nucleoside conjugates. 7. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of ether lipids.
Topics: Animals; Antineoplastic Agents; Cells, Cultured; Cytarabine; Drug Administration Schedule; Humans; Leukemia L1210; Leukemia P388; Mice; Mice, Inbred DBA; Solubility | 1986 |